Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2901354 | Chest | 2012 | 8 Pages |
Abstract
Adding a second walk to the 6-min walk test significantly improves its performance in measuring response to a therapeutic intervention, improves the validity of COPD clinical trials, and would result in a 14% to 33% reduction in sample size requirements. Hence, it should be strongly considered by clinicians and researchers as an outcome measure for therapeutic interventions in patients with COPD.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Divay MD, Robert A. MD, FCCP, Hrishikesh S. MD, Roberto P. MD, FCCP, Gerard MD, FCCP, Barry MD, FCCP, William A. RPFT, Andrew L. MD, MPH, FCCP, John J. MD, FCCP, Fernando J. MD, FCCP, Frank C. MD, FCCP,